Indeksa Nr.
|
Ķīmiskais nosaukums
|
EK Nr.
|
CAS Nr.
|
Klasifikācija
|
Marķējums
|
Specifiskās robežkoncentrācijas, M koeficienti un ATE
|
Piezīmes
|
Bīstamības klases un kategorijas kods
|
Bīstamības apzīmējuma kods
|
Piktogrammas, signālvārda kods
|
Bīstamības apzīmējuma kods
|
Papildu bīstamības apzīmējuma kods
|
“005-007-00-2
|
borskābe [1]
borskābe [2]
|
233-139-2 [1]
234-343-4 [2]
|
10043-35-3 [1]
11113-50-1 [2]
|
Repr. 1B
|
H360FD
|
GHS08
Dgr
|
H360FD”
|
|
|
|
“005-008-00-8
|
dibora trioksīds;
|
215-125-8
|
1303-86-2
|
Repr. 1B
|
H360FD
|
GHS08
Dgr
|
H360FD”
|
|
|
|
“005-011-00-4
|
tetrabora dinātrija heptaoksīds, hidrāts; [1]
dinātrija tetraborāts, bezūdens; [2]
ortoborskābe, nātrija sāls [3]
dinātrija tetraborāta dekahidrāts [4]
dinātrija tetraborāta pentahidrāts [5]
|
235-541-3 [1]
215-540-4 [2]
237-560-2 [3]
215-540-4 [4]
215-540-4 [5]
|
12267-73-1 [1]
1330-43-4 [2]
13840-56-7 [3]
1303-96-4 [4]
12179-04-3 [5]
|
Repr. 1B
|
H360FD
|
GHS08
Dgr
|
H360FD”
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
“006-069-00-3
|
tiofanātmetils (ISO);
dimetil(1,2-fenilēndikarbamotioil)biskarbamāts;
dimetil-4,4′-(o-fenilēn)bis(3-tioalofanāts)
|
245-740-7
|
23564-05-8
|
Carc. 2
Muta. 2
Acute Tox. 4
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
|
H351
H341
H332
H317
H400
H410
|
GHS08
GHS07
GHS09
Wng
|
H351
H341
H332
H317
H410
|
|
ieelpojot: ATE = 1,7 mg/l
(putekļi un migla)
M = 10
M = 10”
|
|
“006-076-00-1
|
mankozebs (ISO); (polimērisks) mangāna etilēnbis(ditiokarbamāta) komplekss savienojums ar cinka sāli
|
–
|
8018-01-7
|
Carc. 2
Repr. 1B
STOT RE 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
|
H351
H360D
H373 (vairogdziedzeris, nervu sistēma)
H317
H400
H410
|
GHS08
GHS07
GHS09
Dgr
|
H351
H360D
H373 (vairogdziedzeris, nervu sistēma)
H317
H410
|
|
M = 10
M = 10”
|
|
“015-113-00-0
|
tolklofosmetils (ISO);
O-(2,6-dihlor-p-tolil)-O,O-dimetiltiofosfāts
|
260-515-3
|
57018-04-9
|
Skin Sens. 1B
Aquatic Acute 1
Aquatic Chronic 1
|
H317
H400
H410
|
GHS07
GHS09
Wng
|
H317
H410
|
|
M = 1
M = 1”
|
|
“028-007-00-4
|
triniķeļa disulfīds;
niķeļa subsulfīds; [1]
heazlewoodite [2]
|
234-829-6 [1]
– [2]
|
12035-72-2 [1]
12035-71-1 [2]
|
Carc. 1A
Muta. 2
Acute Tox. 3
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
|
H350i
H341
H331
H372**
H317
H400
H410
|
GHS08
GHS06
GHS09
Dgr
|
H350i
H341
H331
H372**
H317
H410
|
|
ieelpojot:
ATE = 0,92 mg/l
(putekļi vai migla)”
|
|
“029-002-00-X
|
divara oksīds;
vara(I) oksīds
|
215-270-7
|
1317-39-1
|
Acute Tox. 4
Acute Tox. 4
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
|
H332
H302
H318
H400
H410
|
GHS07
GHS05
GHS09
Dgr
|
H332
H302
H318
H410
|
|
ieelpojot: ATE = 3,34 mg/l (putekļi vai migla)
orāli: ATE = 500 mg uz kg ķermeņa masas
M = 100
M = 10”
|
|
“029-015-00-0
|
vara tiocianāts
|
214-183-1
|
1111-67-7
|
Aquatic Acute 1
Aquatic Chronic 1
|
H400
H410
|
GHS09
Wng
|
H410
|
EUH032
|
M = 10
M = 10”
|
|
“029-016-00-6
|
vara(II) oksīds
|
215-269-1
|
1317-38-0
|
Aquatic Acute 1
Aquatic Chronic 1
|
H400
H410
|
GHS09
Wng
|
H410
|
|
M = 100
M = 10”
|
|
“029-017-00-1
|
divara hlorīda trihidroksīds
|
215-572-9
|
1332-65-6
|
Acute Tox. 4
Acute Tox. 3
Aquatic Acute 1
Aquatic Chronic 1
|
H332
H301
H400
H410
|
GHS06
GHS09
Dgr
|
H332
H301
H410
|
|
ieelpojot: ATE = 2,83 mg/l (putekļi vai migla)
orāli: ATE = 299 mg uz kg ķermeņa masas
M = 10
M = 10”
|
|
“029-018-00-7
|
tetravara heksahidroksīda sulfāts; [1]
tetravara heksahidroksīda sulfāta hidrāts [2]
|
215-582-3 [1]
215-582-3 [2]
|
1333-22-8 [1]
12527-76-3 [2]
|
Acute Tox. 4
Aquatic Acute 1
Aquatic Chronic 1
|
H302
H400
H410
|
GHS07
GHS09
Wng
|
H302
H410
|
|
orāli: ATE = 500 mg uz kg ķermeņa masas
M = 10
M = 10”
|
|
“029-019-01-X
|
vara plēksnes (ar alifātiskās skābes pārklājumu)
|
–
|
–
|
Acute Tox. 3
Acute Tox. 4
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
|
H331
H302
H319
H400
H410
|
GHS06
GHS09
Dgr
|
H331
H302
H319
H410
|
|
ieelpojot: ATE = 0,733 mg/l (putekļi vai migla)
orāli: ATE = 500 mg uz kg ķermeņa masas
M = 10
M = 10”
|
|
“029-020-00-8
|
vara(II) karbonāts--vara(II) hidroksīds (1:1)
|
235-113-6
|
12069-69-1
|
Acute Tox. 4
Acute Tox. 4
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
|
H332
H302
H319
H400
H410
|
GHS07
GHS09
Wng
|
H332
H302
H319
H410
|
|
ieelpojot: ATE = 1,2 mg/l (putekļi vai migla)
orāli: ATE = 500 mg uz kg ķermeņa masas
M = 10
M = 10”
|
|
“029-021-00-3
|
vara dihidroksīds;
vara(II) hidroksīds
|
243-815-9
|
20427-59-2
|
Acute Tox. 2
Acute Tox. 4
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
|
H330
H302
H318
H400
H410
|
GHS06
GHS05
GHS09
Dgr
|
H330
H302
H318
H410
|
|
ieelpojot: ATE = 0,47 mg/l (putekļi vai migla)
orāli: ATE = 500 mg uz kg ķermeņa masas
M = 10
M = 10”
|
|
“029-022-00-9
|
bordo šķidrums;
vara sulfāta un kalcija dihidroksīda reakcijas produkti
|
–
|
8011-63-0
|
Acute Tox. 4
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
|
H332
H318
H400
H410
|
GHS07
GHS05
GHS09
Dgr
|
H332
H318
H410
|
|
ieelpojot: ATE = 1,97 mg/l (putekļi vai migla)
M = 10
M = 1”
|
|
“029-023-00-4
|
vara sulfāta pentahidrāts
|
231-847-6
|
7758-99-8
|
Acute Tox. 4
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
|
H302
H318
H400
H410
|
GHS07
GHS05
GHS09
Dgr
|
H302
H318
H410
|
|
orāli: ATE = 481 mg uz kg ķermeņa masas
M = 10
M = 1”
|
|
“601-029-00-7
|
dipentēns;
limonēns [1]
(S)-p-menta-1,8-diēns; l-limonēns; [2]
trans-1-metil-4-(1-metilvinil)cikloheksēns; [3]
(±)-1-metil-4-(1-metilvinil)cikloheksēns [4]
|
205-341-0 [1]
227-815-6 [2]
229-977-3 [3]
231-732-0 [4]
|
138-86-3 [1]
5989-54-8 [2]
6876-12-6 [3]
7705-14-8 [4]
|
Flam. Liq. 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
|
H226
H315
H317
H400
H410
|
GHS02
GHS07
GHS09
Wng
|
H226
H315
H317
H410
|
|
|
C”
|
“601-096-00-2
|
(R)-p-menta-1,8-diēns;
d-limonēns
|
227-813-5
|
5989-27-5
|
Flam. Liq. 3
Skin Irrit. 2
Skin Sens. 1B
Asp. Tox. 1
Aquatic Acute 1
Aquatic Chronic 3
|
H226
H315
H317
H304
H400
H412
|
GHS02
GHS07
GHS08
GHS09
Dgr
|
H226
H315
H317
H304
H410
|
|
M = 1”
|
|
“603-024-00-5
|
1,4-dioksāns
|
204-661-8
|
123-91-1
|
Flam. Liq. 2
Carc. 1B
STOT SE 3
Eye Irrit. 2
|
H225
H350
H335
H319
|
GHS02
GHS08
GHS07
Dgr
|
H225
H350
H335
H319
|
EUH019
EUH066
|
|
D”
|
“603-066-00-4
|
7-oksa-3-oksiranilbiciklo[4.1.0]heptāns; 1,2-epoksi-4-epoksietilcikloheksāns; 4-vinilcikloheksēna diepoksīds
|
203-437-7
|
106-87-6
|
Carc. 1B
Muta. 2
Repr. 1B
Acute Tox. 3
Acute Tox. 4
|
H350
H341
H360F
H331
H302
|
GHS08
GHS06
Dgr
|
H350
H341
H360F
H331
H302
|
|
ieelpojot: ATE = 0,5 mg/l (putekļi vai migla)
orāli: ATE = 1 847 mg uz kg ķermeņa masas”
|
|
“603-098-00-9
|
2-fenoksietanols
|
204-589-7
|
122-99-6
|
Acute Tox. 4
STOT SE 3
Eye Dam. 1
|
H302
H335
H318
|
GHS05
GHS07
Dgr
|
H302
H335
H318
|
|
orāli:
ATE = 1 394 mg uz kg ķermeņa masas”
|
|
“606-004-00-4
|
4-metilpentān-2-ons; izobutilmetilketons
|
203-550-1
|
108-10-1
|
Flam. Liq. 2
Carc. 2
Acute Tox. 4
STOT SE 3
Eye Irrit. 2
|
H225
H351
H332
H336
H319
|
GHS02
GHS07
GHS08
Dgr
|
H225
H351
H332
H336
H319
|
EUH066
|
ieelpojot: ATE = 11 mg/l (tvaiki)”
|
|
“607-421-00-4
|
cipermetrīns (ISO);
α-ciān-3-fenoksibenzil-3-(2,2-dihlorvinil)-2,2-dimetilciklopropānkarboksilāts; cipermetrīns, cis/trans, +/-40/60
|
257-842-9
|
52315-07-8
|
Acute Tox. 4
Acute Tox. 4
STOT SE 3
STOT RE 2
Aquatic Acute 1
Aquatic Chronic 1
|
H332
H302
H335
H373 (nervu sistēma)
H400
H410
|
GHS07
GHS08
GHS09
Wng
|
H332
H302
H335
H373 (nervu sistēma)
H410
|
|
orāli: ATE = 500 mg uz kg ķermeņa masas
ieelpojot: ATE = 3,3 mg/l (putekļi vai migla)
M = 100000
M = 100000”
|
|
“607-424-00-0
|
trifloksistrobīns (ISO); metil(E)-metoksimino-{(E)-α-[1-(α,α,α-trifluor-m-tolil)etilidēnaminooksi]-o-tolil}acetāts
|
–
|
141517-21-7
|
Lact.
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
|
H362
H317
H400
H410
|
GHS07
GHS09
Wng
|
H362
H317
H410
|
|
M = 100
M = 10”
|
|
“607-434-00-5
|
mekoprops-P [1] un tā sāļi;
(R)-2-(4-hlor-2-metilfenoksi)propionskābe [1] un tās sāļi
|
240-539-0 [1]
|
16484-77-8 [1]
|
Acute Tox. 4
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
|
H302
H318
H400
H410
|
GHS07
GHS05
GHS09
Dgr
|
H302
H318
H410
|
|
orāli: ATE = 431 mg uz kg ķermeņa masas
M = 10
M = 10”
|
|
“608-058-00-4
|
esfenvalerāts (ISO);
(S)-α-ciān-3-fenoksibenzil-(S)-2-(4-hlorfenil)-3-metilbutirāts
|
–
|
66230-04-4
|
Acute Tox. 3
Acute Tox. 3
STOT SE 1
STOT RE 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
|
H331
H301
H370 (nervu sistēma)
H373
H317
H400
H410
|
GHS06
GHS08
GHS09
Dgr
|
H331
H301
H370 (nervu sistēma)
H373
H317
H410
|
|
orāli: ATE = 88,5 mg uz kg ķermeņa masas
ieelpojot: ATE = 0,53 mg/l (putekļi vai migla)
M = 10 000
M = 10 000 ”
|
|
“612-067-00-9
|
3-aminometil-3,5,5-trimetilcikloheksilamīns
|
220-666-8
|
2855-13-2
|
Acute Tox. 4
Skin Corr. 1B
Eye Dam. 1
Skin Sens. 1A
|
H302
H314
H318
H317
|
GHS05
GHS07
Dgr
|
H302
H314
H317
|
|
orāli: ATE = 1 030 mg uz kg ķermeņa masas
Skin Sens. 1A; H317: C ≥ 0,001 %”
|
|
“612-252-00-4
|
imidakloprīds (ISO);
(E)-1-(6-hlor-3-piridilmetil)-N-nitroimidazolidīn-2-ilidēnamīns;
(2E)-1-[(6-hlorpiridīn-3-il)metil]-N-nitroimidazolidīn-2-imīns
|
428-040-8
|
138261-41-3
|
Acute Tox. 3
Aquatic Acute 1
Aquatic Chronic 1
|
H301
H400
H410
|
GHS06
GHS09
Dgr
|
H301
H410
|
|
orāli: ATE = 131 mg uz kg ķermeņa masas
M = 100
M = 1 000 ”
|
|
“613-048-00-8
|
karbendazīms (ISO); metilbenzimidazol-2-ilkarbamāts
|
234-232-0
|
10605-21-7
|
Muta. 1B
Repr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
|
H340
H360FD
H317
H400
H410
|
GHS07
GHS08
GHS09
Dgr
|
H340
H360FD
H317
H410
|
|
M = 10
M = 10”
|
|
“613-102-00-0
|
dimetomorfs (ISO); (E,Z)-4-(3-(4-hlorfenil)-3-(3,4-dimetoksifenil)akriloil)morfolīns
|
404-200-2
|
110488-70-5
|
Repr. 1B
Aquatic Chronic 2
|
H360F
H411
|
GHS08
GHS09
Dgr
|
H360F
H411”
|
|
|
|
“613-111-00-X
|
1,2,4-triazols
|
206-022-9
|
288-88-0
|
Repr. 1B
Acute Tox. 4
Eye Irrit. 2
|
H360FD
H302
H319
|
GHS08
GHS07
Dgr
|
H360FD
H302
H319
|
|
orāli: ATE = 1 320 mg uz kg ķermeņa masas”
|
|
“613-166-00-X
|
flumioksazīns (ISO);
N-(7-fluor-3,4-dihidro-3-okso-4-prop-2-inil-2H-1,4-benzoksazīn-6-il)cicloheks-1-ēn-1,2-dikarboksimīds
|
–
|
103361-09-7
|
Repr. 2
Aquatic Acute 1
Aquatic Chronic 1
|
H361d
H400
H410
|
GHS08
GHS09
Wng
|
H361d
H410
|
|
M = 1 000
M = 1 000 ”
|
|
“613-208-00-7
|
imazamokss (ISO);
(RS)-2-(4-izopropil-4-metil-5-okso-2-imidazolīn-2-il)-5-metoksimetilnikotīnskābe
|
–
|
114311-32-9
|
Repr. 2
Aquatic Acute 1
Aquatic Chronic 1
|
H361d
H400
H410
|
GHS08
GHS09
Wng
|
H361d
H410
|
|
M = 10
M = 10”
|
|
“613-267-00-9
|
tiametoksāms (ISO);
3-(2-hlortiazol-5-ilmetil)-5-metil[1,3,5]oksadiazinān-4-ilidēn-N-nitroamīns
|
428-650-4
|
153719-23-4
|
Repr. 2
Acute Tox. 4
Aquatic Acute 1
Aquatic Chronic 1
|
H361fd
H302
H400
H410
|
GHS07
GHS08
GHS09
Wng
|
H361fd
H302
H410
|
|
orāli: ATE = 780 mg uz kg ķermeņa masas
M = 10
M = 10”
|
|
“613-282-00-0
|
tritikonazols (ISO);
(RS)-(E)-5-(4-hlorbenzilidēn)-2,2-dimetil-1-(1H-1,2,4-triazol-1-metil)ciklopentanols
|
–
|
138182-18-0
|
Repr. 2
STOT RE 2
Aquatic Acute 1
Aquatic Chronic 1
|
H361f
H373
H400
H410
|
GHS08
GHS09
Wng
|
H361f
H373
H410
|
|
M = 1
M = 1”
|
|
“616-032-00-9
|
diflufenikāns (ISO);
N-(2,4-difluorfenil)-2-[3-(trifluormetil)fenoksi]-3-piridīnkarboksamīds; 2′,4′-difluor-2-(α,α,α-trifluor-m-toliloksi)nikotīnanilīds
|
–
|
83164-33-4
|
Aquatic Acute 1
Aquatic Chronic 1
|
H400
H410
|
GHS09
Wng
|
H410
|
|
M = 10 000
M = 1 000 ”
|
|
“616-106-00-0
|
fenmedifāms (ISO); metil-3-(3-metilkarbaniloiloksi)karbanilāts
|
237-199-0
|
13684-63-4
|
Aquatic Acute 1
Aquatic Chronic 1
|
H400
H410
|
GHS09
Wng
|
H410
|
|
M = 10
M = 10”
|
|
“616-113-00-9
|
desmedifāms (ISO);
etil-3-fenilkarbamoiloksifenilkarbamāts
|
237-198-5
|
13684-56-5
|
Repr. 2
Aquatic Acute 1
Aquatic Chronic 1
|
H361d
H400
H410
|
GHS08
GHS09
Wng
|
H361d
H410
|
|
M = 10
M = 10”;
|
|